V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013463 | 220007870 | 1.4 | 57.1 | Adjuvant (A) | 2013-03-19 | 2013-04-22 | Hydroxycarbamide | N | N | 220030214 | HYDROXYCARBAMIDE |
| 220013464 | 220017815 | 1.81 | 0 | Disease modification (D) | 2013-08-03 | 2013-12-06 | Hydroxycarbamide | N | N | 220030215 | HYDROXYCARBAMIDE |
| 220013465 | 220007871 | 1.82 | 34.2 | Curative (C) | 2013-08-04 | 2013-09-12 | AML Interim Guidelines FLA -Ida | 02 | N | 220030216 | NOT MATCHED |
| 220013466 | 220014324 | 1.8 | 86.5 | Palliative (P) | null | 2015-05-30 | Cytarabine Low Dose | N | N | 220030217 | CYTARABINE |
| 220013469 | 220007873 | 1.04 | null | Palliative (P) | 2016-10-31 | 2017-03-26 | Hydroxycarbamide | N | N | 220030225 | HYDROXYCARBAMIDE |
| 220013470 | 220007877 | 0 | 48 | Palliative (P) | 2017-08-28 | 2017-08-28 | Hydroxycarbamide | N | N | 220030228 | HYDROXYCARBAMIDE |
| 220013471 | 220007877 | 1.86 | null | Curative (C) | 2016-12-17 | 2016-12-21 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220030228 | CYTARABINE |
| 220013472 | 220014329 | null | 65.1 | Curative (C) | 2017-03-02 | 2017-03-02 | AML Interim Guidelines FLA | N | N | 220030235 | NOT MATCHED |
| 220013473 | 220007882 | 1.73 | null | Disease modification (D) | null | 2017-08-30 | Hydroxycarbamide | N | N | 220030236 | HYDROXYCARBAMIDE |
| 220013474 | 220007883 | 1.83 | 63.3 | Palliative (P) | 2016-11-27 | 2016-12-12 | CYTARABINE | null | null | 220030238 | CYTARABINE |
| 220013475 | 220007883 | 1.77 | 82 | Curative (C) | 2016-04-24 | 2016-04-24 | AML MyeChild 01 FLA-Idarubicin | 2 | N | 220030238 | NOT MATCHED |
| 220013476 | 220007883 | 1.63 | null | Curative (C) | 2013-04-04 | 2013-04-18 | CYTARABINE | 99 | N | 220030238 | CYTARABINE |
| 220013477 | 220007883 | 1.7 | 85.6 | Neo-adjuvant (N) | 2015-01-15 | 2015-01-15 | Hydroxycarbamide | 02 | N | 220030238 | HYDROXYCARBAMIDE |
| 220013478 | 220007886 | 1.81 | 13.6 | Disease modification (D) | 2014-06-16 | 2014-06-16 | null | N | N | 220030255 | NOT MATCHED |
| 220013479 | 220007887 | 1.86 | 0 | Palliative (P) | 2016-07-20 | 2016-07-20 | Hydroxycarbamide | N | N | 220030261 | HYDROXYCARBAMIDE |
| 220013483 | 220007891 | 0 | 87.1 | Not known (9) | null | 2014-06-14 | Cytarabine Low Dose | 02 | N | 220030274 | CYTARABINE |
| 220013484 | 220014333 | 1.44 | 96.7 | Disease modification (D) | 2017-04-08 | 2017-04-19 | CYTARABINE | null | null | 220030275 | CYTARABINE |
| 220013485 | 220007894 | null | 35 | null | 2017-12-14 | 2017-12-14 | ATG + Cyclophosphamide TBI Allo | 01 | N | 220030276 | NOT MATCHED |
| 220013486 | 220007896 | null | 101 | Palliative (P) | null | 2014-01-21 | Hydroxycarbamide | null | null | 220030281 | HYDROXYCARBAMIDE |
| 220013488 | 220007899 | null | 0 | Palliative (P) | 2013-07-11 | 2013-07-25 | CYTARABINE | N | N | 220030289 | CYTARABINE |
| 220013489 | 220007900 | 1.78 | 66.5 | Palliative (P) | 2014-07-08 | 2014-07-27 | AML Interim Guidelines FLA -Ida | 02 | N | 220030292 | NOT MATCHED |
| 220013490 | 220007901 | null | 62.2 | null | 2016-01-29 | 2016-02-08 | AML Interim Guidelines FLA | null | null | 220030292 | NOT MATCHED |
| 220013491 | 220014336 | null | 38.4 | Palliative (P) | 2014-08-18 | 2014-08-18 | AML Relapsed High Dose Cytarabine | N | N | 220030293 | NOT MATCHED |
| 220013492 | 220014336 | null | 6.9 | Palliative (P) | 2018-01-19 | 2018-01-28 | AML MyeChild 01 FLA-Idarubicin | N | N | 220030293 | NOT MATCHED |
| 220013493 | 220007904 | null | null | Palliative (P) | 2017-02-26 | 2017-03-02 | Cytarabine Low Dose | 2 | N | 220030299 | CYTARABINE |
| 220013494 | 220007907 | null | 22.9 | Curative (C) | 2014-04-16 | 2014-04-30 | AML MyeChild 01 IT Cyt | 02 | N | 220030302 | NOT MATCHED |
| 220013495 | 220007909 | null | 54 | Disease modification (D) | 2016-11-21 | 2016-11-21 | Hydroxycarbamide | N | N | 220030302 | HYDROXYCARBAMIDE |
| 220013496 | 220007910 | 1.55 | 51.2 | Curative (C) | 2016-12-21 | 2016-12-21 | Hydroxycarbamide | 99 | N | 220030307 | HYDROXYCARBAMIDE |
| 220013497 | 220014340 | 1.6 | null | Curative (C) | 2016-07-09 | 2016-07-30 | Cytarabine Low Dose | 1 | N | 220030309 | CYTARABINE |
| 220013498 | 220007911 | null | 9.7 | Palliative (P) | 2016-11-24 | 2016-12-09 | null | N | N | 220030310 | NOT MATCHED |
| 220013499 | 220007912 | 0 | 59.6 | Disease modification (D) | 2017-03-29 | 2017-03-29 | CYTARABINE | N | N | 220030311 | CYTARABINE |
| 220013501 | 220007913 | null | 0 | Adjuvant (A) | 2016-03-07 | 2017-02-15 | Hydroxycarbamide | 02 | N | 220030313 | HYDROXYCARBAMIDE |
| 220013502 | 220007913 | 1.6 | 10 | Curative (C) | null | 2014-08-04 | ATG + Cyclophosphamide TBI Allo | 99 | null | 220030313 | NOT MATCHED |
| 220013503 | 220007914 | 1.69 | 111.8 | Not known (9) | 2014-12-07 | 2014-12-19 | Cytarabine low (10to20mg/m2) IV/SC | Y | N | 220030316 | CYTARABINE |
| 220013504 | 220007917 | 1.56 | null | null | 2017-07-01 | 2017-07-02 | Hydroxycarbamide | null | N | 220030318 | HYDROXYCARBAMIDE |
| 220013505 | 220007918 | null | 5.8 | Palliative (P) | null | 2014-12-21 | AML MyeChild 01 IT Cyt | 02 | N | 220030319 | NOT MATCHED |
| 220013506 | 220007919 | 1.77 | 87.7 | Curative (C) | 2017-05-12 | 2017-05-16 | Cytarabine Low Dose | N | N | 220030320 | CYTARABINE |
| 220013507 | 220007920 | 1.56 | 16.6 | Curative (C) | 2017-06-14 | 2017-06-14 | AML MyeChild 01 A Mitozantrone/Cytarabine | null | null | 220030322 | NOT MATCHED |
| 220013508 | 220007921 | null | 38.4 | Adjuvant (A) | 2014-01-25 | 2014-01-26 | null | null | null | 220030324 | NOT MATCHED |
| 220013509 | 220007922 | 1.75 | 76.5 | Curative (C) | 2017-07-10 | 2017-07-21 | ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYCLOPHOSPHAMIDE | 2 | N | 220030325 | NOT MATCHED |
| 220013510 | 220007923 | null | null | Palliative (P) | null | 2016-01-25 | Cytarabine Low Dose | N | null | 220030329 | CYTARABINE |
| 220013511 | 220014346 | null | 77.4 | Curative (C) | 2015-02-14 | 2015-05-16 | FBC Conditionining | null | N | 220030332 | NOT MATCHED |
| 220013512 | 220014346 | null | 96.7 | Curative (C) | null | 2018-03-14 | Cytarabine Low Dose | N | N | 220030332 | CYTARABINE |
| 220013513 | 220019778 | 0 | 69.5 | Adjuvant (A) | 2015-01-16 | 2015-01-16 | Cytarabine Low Dose | N | N | 220030337 | CYTARABINE |
| 220013514 | 220007925 | 1.77 | 77.4 | Curative (C) | 2013-08-10 | 2013-09-20 | null | N | N | 220030339 | NOT MATCHED |
| 220013515 | 220017824 | 1.68 | 11.2 | Curative (C) | 2017-01-06 | 2017-01-26 | AML Downs haM | N | N | 220030339 | NOT MATCHED |
| 220013516 | 220017824 | 1.56 | 59.4 | Disease modification (D) | 2015-10-23 | 2015-11-08 | Hydroxycarbamide | N | N | 220030339 | HYDROXYCARBAMIDE |
| 220013517 | 220007927 | 0 | null | Palliative (P) | null | 2014-11-23 | Hydroxycarbamide | N | N | 220030348 | HYDROXYCARBAMIDE |
| 220013518 | 220007927 | 1.73 | 18.6 | Curative (C) | 2014-09-06 | 2014-11-14 | Quizartinib (AC220) | N | null | 220030348 | NOT MATCHED |
| 220013519 | 220019780 | null | null | Curative (C) | 2013-06-17 | 2013-07-04 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030353 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |